DUBLIN–(BUSINESS WIRE)–The “Dry Eye Syndrome Global Market Report 2024” report has been added to ResearchAndMarkets.com’s offering. This research publication sheds light on the robust growth and pivotal trends propelling the sector forward, ensuring …
Category: Business
Global Allergy Conjunctivitis Market Projected to Reach $3.2 Billion by 2028, Driven by Increasing Allergies and Technological Innovations – Long-term Forecast to 2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergy Conjunctivitis Global Market Report 2024” report has been added to ResearchAndMarkets.com’s offering. Market Expansion Driven by Increasing Allergies and Technological Innovations in Treatment The global allergy co…
EyeCare Partners Announces New Refractive Cataract Anterior Segment Fellowship and Launch of ECP Foundation
ST. LOUIS–(BUSINESS WIRE)– #ASCRS–EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, continues to advance leadership and research at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting…
Wearing Glasses Boosts Income by a Third in Low-Income Communities, Finds Landmark New Study
NEW YORK–(BUSINESS WIRE)–A pair of reading glasses increases the earnings of people in low- income communities by 33% according to new research. A new randomised controlled trial, published today, finds that the provision of reading glasses improves …
Southern California College of Optometry Celebrates 120 Years of Educational and Clinical Excellence
FULLERTON, Calif.–(BUSINESS WIRE)–Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution headquartered in Fullerton, Calif. proudly celebrates the 120th anniversary of its Southern California Co…
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced the U….
LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials
SAN DIEGO–(BUSINESS WIRE)–LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop to improve near vision in people with presbyopia, t…
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), to Present Data on LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc. will be presenting data on LACRIFILL® Canalicular Gel during the ASCRS Annual Meeting in Boston, MA on April 5-8, 2024.
Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
SEATTLE, CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced several presentations during the 2024 American Society of Cataract…
ADDING MULTIMEDIA Eye Physicians of Libertyville Acquires Northern Illinois Eye Clinic
LIBERTYVILLE, Ill.–(BUSINESS WIRE)–Effective March 28, 2024, Eye Physicians of Libertyville doctors will assume care for Northern Illinois Eye Clinic patients. “Dr. Velotta is a well-respected ophthalmologist in our community, and I wish her the best…
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that i…
Global Sports Optics Analysis 2023: A $2.73 Billion Market by 2029 Featuring Key vendors – Nikon, Swarovski, Beretta, Vortex, Leica Camera, Carlyle group, ATN, and Trijicon Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Sports Optics Market: Analysis By Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029” report has been added to ResearchAndMarkets.com’s offering. The global sports optics market value st…
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced the pricing o…
MyEyeDr. Partners with Prevent Blindness to Promote Eye Health and Safety During April 8 Solar Eclipse, Gives Away Solar Glasses at 400+ Locations
VIENNA, Va.–(BUSINESS WIRE)–Ahead of the total solar eclipse on Monday, April 8, MyEyeDr., a leading provider of eye health services with over 800 locations across the U.S., is educating consumers about the importance of eye health and the need for p…
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry
PLEASANTON, Calif.–(BUSINESS WIRE)– #Ophthalmology–RadiusXR, the trailblazer in Digital Health, announces the publication of its groundbreaking NOVA Clinical Trial in Translational Vision Science and Technology (TVST), a prestigious journal by the A…
Horus Pharma Renews Its Partnership With Plastic Bank
NICE, France–(BUSINESS WIRE)–Horus Pharma, an independent French laboratory specialised in ophthalmology known for its expertise in developing preservative-free products designed to facilitate eye and eyelid health, has extended its successful collab…
GenSight Biologics Reports Full Year 2023 Consolidated Financial Results
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress
SAN DIEGO–(BUSINESS WIRE)–LENZ Therapeutics, Inc. (Nasdaq: LENZ) (LENZ or the Company), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop that has been shown to improve near vision in people wit…
GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections Four Years After One-Time Administration
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics confirme l’efficacité et la sécurité durables des injections bilatérales de LUMEVOQ® quatre ans après une administration unique
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible au PEA-PME), une société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les …